Insight

Brandon Huffman: Exciting translational work happening at Dana-Farber Cancer Institute

Photo from Brandon Huffman/X

Feb 19, 2024, 09:20

Brandon Huffman: Exciting translational work happening at Dana-Farber Cancer Institute

Brandon Huffman, Medical Oncologist in the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute, shared an X post by James Cleary, Medical Oncologist in the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute, adding:

“Congratulations to Harsh Singh, James Cleary, and the team on a very well-done description of the unique entity – HER2 (ERBB2) amplified CRC! Exciting translational work happening at Dana-Farber Cancer Institute!”

Quoting James Cleary’s post:

“In this collaboration with Harsh Singh, Lab Sethi, Jason Hornick we examined mechanisms of resistance and sensitivity to targeted therapy in HER2 amplified colorectal cancer.”

Proceed to the article.
Source: Brandon Huffman/X and James Cleary/X

Brandon Huffman cancer colorectal cancer Dana-Farber Cancer Institute Dana-Farber Gastrointestinal Cancer Center Dana-Farber's Young-Onset Colorectal Cancer Center Harsh Singh HER2 amplified colorectal cancer James Cleary Jason Hornick Lab Sethi OncoDaily Oncology

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer